๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Tilarginine Acetate Injection is a new type of drug that temporarily stops ...
Status
Terminated
Location
The Heart Group, PC
Start Date
2005-05
Trial ID
NCT00112281
Treatments Being Tested
This laboratory study is looking at response or resistance to chemotherapy ...
Status
Completed
Location
Children's Oncology Group
Start Date
2003-11
Trial ID
NCT00898404
Treatments Being Tested
The TaRGET study is a multi-centre, prospective, randomized, double-blind, ...
Status
Recruiting
Location
University of Calgary
Start Date
2025-03-21
Trial ID
NCT06174220
Treatments Being Tested
RBS2418 is a specific immune modulator that works through the inhibition of...
Status
Recruiting
Location
Christiana Care
Start Date
2025-01-17
Trial ID
NCT06824064
To determine if the regorafenib and nivolumab combination (RegoNivo) improv...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2021-05-05
Trial ID
NCT04879368
Treatments Being Tested
This is a phase 2B, open label study, that will compare the safety and effi...
Status
Unknown
Location
TASK Applied Sciences Clinical Research Centre
Start Date
2023-09-21
Trial ID
NCT05926466
Treatments Being Tested
This open-label, single-arm study will evaluate the efficacy and safety of ...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT00996606
Treatments Being Tested
This phase I trial studies the side effects and best dose of papaverine (PP...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-04-07
Trial ID
NCT06834126
This is a tissue and blood collection protocol requiring image-guided biops...
Status
Active Not Recruiting
Location
University of California, San Francisco
Start Date
2016-05-25
Trial ID
NCT02735252
Treatments Being Tested
This phase II trial investigates the effect of nivolumab and ipilimumab whe...
Status
Active Not Recruiting
Location
Mobile Infirmary Medical Center
Start Date
2022-02-08
Trial ID
NCT04751370